Bremazocine: a potent, long-acting opiate kappa-agonist.
D000698:Analgesia; D000818:Animals; D001575:Benzomorphans / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism; D003496:Cyclazocine / Q000031:analogs & derivatives / Q000494:pharmacology; D004558:Electric Stimulation; D016314:Ethylketocyclazocine / Q000031:analogs & derivatives*; D006168:Guinea Pigs; D007082:Ileum / Q000378:metabolism; D008253:Macaca mulatta; D008297:Male; D051379:Mice; D009019:Morphinans / Q000494:pharmacology*; D009020:Morphine / Q000008:administration & dosage / Q000494:pharmacology; D009270:Naloxone / Q000494:pharmacology; D010423:Pentazocine / Q000494:pharmacology; D051381:Rats; D011957:Receptors, Opioid / Q000378:metabolism*; D017473:Receptors, Opioid, kappa; D014649:Vas Deferens / Q000378:metabolism
D001575:Benzomorphans; D009019:Morphinans; D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa; D009270:Naloxone; C027247:MR 2266; D016314:Ethylketocyclazocine; C012395:ketazocine; D009020:Morphine; C027248:bremazocine; D003496:Cyclazocine; D010423:Pentazocine